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Table. Mean MR Grade, 6MWD and NYHA through 12 months (p value
compared to baseline)
Baseline 1 month 6 months* 12 months*
Mean MR
Grade
2.73 0.6
(N¼26)
1.57 0.95
(N¼23,
1.35 0.79
(N¼17,
1.13 0.89
(N¼16,
SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.com66 (84.64%) patients with sustained immediate clinical and echocardiographic
improvements.
Conclusions: Both Inoue and the multi-track balloon systems achieved successful
immediate and 18-month results. The multi-track double balloon system produced
signiﬁcantly larger MVA, with better bilateral commissurotomy,yet with longer pro-
cedure and ﬂuoroscopy times.p<0.001) p<0.001) p<0.001)
Mean 6MWD
(m)
291.2
82.6
(N¼28)
376.2
100.8
(N¼25,
p<0.001)
419.9
116.3
(N¼14,
p<0.001)
383.8
142.1
(N¼16,
p¼0.002)
Mean NYHA
Class
3.03
0.42
(N¼29)
2.11 0.57
(N¼28,
p<0.001)
2.05 0.71
(N¼19,
p<0.001)
2.06 0.66
(N¼17,
p<0.001)
* Preliminary Data - data collection not completeTCT-814
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Background: The non-planar, saddle-shaped structure of the mitral annulus has been
well established through decades of anatomical and echocardiographic study. Its
relevance for mitral annular assessment for transcatheter mitral valve implantation
(TMVI) is uncertain. We sought to deﬁne the methodology for computed tomography
(CT)-based “D -shaped’ mitral annular assessment for TMVI and compare these
measurements to traditional “saddle-shaped” mitral annular assessment.
Methods: ECG-gated, end-diastolic CT data of 28 patients with severe functional
mitral regurgitation was analyzed. The annular contour was segmented and ﬁbrous
trigones were identiﬁed yielding annular perimeter, projected area, inter-trigone (TT)
and septal-lateral (SL) distances and annular height. The traditional saddle shaped
annulus was deﬁned including the aortomitral continuity. The D-shaped annulus was
deﬁned as being limited anteriorly by the TT line, excluding the aortomitral conti-
nuity. Hypothetical left ventricular outﬂow tract (LVOT) clearance and orthogonal
projection angles were assessed.
Results: Projected area, perimeter and SL distance were found to be signiﬁcantly
smaller for the D-shaped annulus than for the saddle-shaped annulus (11.22.7cm2
vs. 13.03.0cm2, 124.115.1mm vs. 136.015.5mm, 32.14.0mm vs.
40.14.9mm respectively, p< 0.001). TT distances were identical (32.74.1mm).
The D-shaped annulus was more planar demonstrating a reduced annular height
(2.41.0mm vs. 10.61.8mm, p< 0.001). LVOT clearance was signiﬁcantly
reduced for the saddle-shaped annulus, but preserved for the D-shaped annulus
(10.72.2mm vs. 17.53.0mm, p< 0.001). A line of perpendicularity for orthogonal
views was identiﬁed. SL views were on average found at 25.57.7 RAO,
22.510.2 cranial, whereas TT views were found at 74.720.5 RAO, 57.08.4
caudal.
Conclusions: The historically established methodology for mitral annulus sizing
appears inappropriate for TMVI, yielding signiﬁcantly larger dimensions compared to
the D-shaped annulus approach with resultant signiﬁcantly reduced LVOT clearance.
CT-based mitral annular assessment may aid pre-procedural sizing, ensuring appro-
priate patient and device selection and guide device deployment.TCT-815
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Background: Functional mitral regurgitation (FMR) contributes to both morbidity
and mortality of patients with systolic heart failure. Percutaneous mitral
annuloplasty (PMA), using the Carillon Mitral Contour System, to reduce FMR is
feasible in these patients. The aim of the study was to assess whether the reduction of
FMR associated with PMA will result in clinical beneﬁt as measured by exercise
capacity.
Methods: Patients with NYHA II-IV heart failure and stable medical therapy, mod-
erate to severe FMR, and LVEF< 40% underwent PMA. Clinical measures of efﬁcacy
including NYHA and six minute walk distance (6MWD) were collected through
12 months.
Results: At baseline, dilated cardiomyopathy was of ischemic origin in 60% of pa-
tients, mean EF was 32.3%, and mean LV end diastolic dimension was 6.4 cm.
Carillon device placement was achieved in 30/36 patients (83%). The major adverse
event rate at 30-days for all 36 attempted patients was 2.8% (one death unrelated to
the procedure or the device). There were no device related major adverse events
through 12 months. The 12-month mortality was 23%. The changes in mean MR
Grade, 6MWD and NYHA classiﬁcation through 12 months are detailed in the table
below.B238 JACC Vol 64/11/Suppl B j September 13–17, 2014 j TConclusions: Implantation of the modiﬁed Carillon device using reﬁned procedural
techniques was safe, resulted in an improved implant rate and reduction in FMR and
was associated with marked symptomatic and functional improvement.TCT-816
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Background: Percutaneous mitral valvuloplasty (PMB) has been described as a
feasible alternative option for surgical commissurotomy among patients with
mitral valve stenosis. We aimed to evaluate the post procedures outcomes and
its clinical signiﬁcance on long term follow up between these two treatment
modalities.
Methods: Pub Med, Cochrane and Scopus were systematically searched up to
May 2014. Subjects of analysis were post procedure hemodynamic analysis of mitral
valve area by Gorlin formula and transmitral gradient. Post procedure long
term follow-up outcomes were analyzed by MVA, mitral valve re-stenosis, new or
increase of mitral regurgitation, and poor clinical status as NYHA class III/IV. We
used Fixed or Random Effect analysis using the Cochrane Handbook of Systematic
Reviews.
Results: A total of 9 RCTs were selected and provided a total of 1200 patients on the
PBM group and 1020 patients on the surgical group. The PMB presented with a trend
towards higher MVA with signiﬁcant decrease of the transmitral gradient (Figure 1).
Clinical follow up disclosed no difference among groups (Figure 2).CT Abstracts/Valvular disease - Mitral: Transcatheter therapies (non-MitraClip)
Table 1
12 month 24 m 36 m 48 m 60 m 72 m
MVA (group A); Cm2 1,60 1,64 1,67 1,59 1,54 1,52
MVA (group B) 1,64 1,56 1,54 1,64 1,51 1,47
PAPs (Group A); mmHg 35 32 36 38 34 37
PAPs (Group B) 30 30 30 31 33 31,5
www.jacctctabstracts2014.com SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PMConclusions: Our analysis could suggest that PMB might be non-inferior to surgical
commissurotomy presenting with good post procedural outcomes and similar clinical
results. Therefore further larger clinical randomized studies are warranted.
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Background: OBJETIVE:assess the long-term clinical, echocardiographic and he-
modynamics effects of percutaneous mitral balloon valvuloplasty (PMV) on
patients(pts)with pulmonary hypertension(PHT).
Methods: PMV was performed in 157 consecutive pts. 47 (29,9%) had PHT deﬁned
as resting pulmonary artery systolic pressure (PAPs) > 50 mmHg at baseline (group
A), and 110 controls pts(70,1%) (group B). Pts were clinical and echocardiographicaly
evaluated immediately after procedure 6 months after and once per year thereafter.
Following endpoints were considered: restenosis(RS),mitral valve replacement
(MVR) or MBV requirement, or cardiovascular death. A logistic regression model
was adjusted to determine independent predictors for outcome. A value of p < 0.05
was considered signiﬁcant.
Results: Median follow-up was 48 months (Q25-75: 24-84). Group A pts aged
43,7 12 years; 89,3% (42 pts) were female; 23,4% pts had atrial ﬁbrillation (AF).
Median ES was 7(Q25-75: 5-9).No diferences on baseline characteristics, successJACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/Vasculachievement, RS and follow up symptoms between Groups were found. PMV
inmediate success was 76.6% in Group A and 80% in Group B (P¼NS).MVA
increased from 0,90 cm2 to 1,75 cm2. PAPs fell from 57,5 mmhg to 35 mmHg in
Group A and from 38 mmhg to 30 mmHg in Group B. Success was associated with
ES < 8 (p¼0.01) both in group A and B. Long term outcomes are shown in table 1.
There were 3 in hospital deaths and 3 deaths during follow-up. 10 pts required newPMV; 6 p RVM. RS at 60 months follow-up was associated with ES > 8 in both
groups, A (p¼ 0,03) B (p¼ 0,02).
Conclusions: PMV is a safe and effective technique for treating patients with mitral
stenosis and PHT. Despite a gradual MVA decrease, most patients remain asymp-
tomatic and PAPs values were stable in the long term follow up.Vascular Access and Intervention - Transradial
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Background: Percutaneous coronary intervention (PCI) by the transradial approach
(TRA) is increasing adopted in most countries with the advantage of fewer vascular
complications compared with the transfemoral approach (TFA). Women are associ-
ated with higher risk of bleeding and access site complications undergoing PCI. So we
performed this study to compare the effect of TRA vs. TFA in women patients.
Methods: From July,2006 to Aug,2011, 4755 women patients who have undergone
PCI with stent implantation were included in the analysis. The primary endpoint
was deﬁned as in-hospital net adverse clinical events (NACE), which was a composite
of all-cause death, myocardial infarction (MI), target vessel revascularization
(TVR), stroke and major bleeding. The secondary endpoint was deﬁned as major
adverse cardiovascular events (MACE) which included all-cause death, MI and TVR.
Propensity score (PS) matching was performed to minimize the baseline disparity.
Results: Among 4755 women patients, 3801 (80%) patients were in the TRA group,
and 954 (20%) were in the TFA group. 563 pairs matched after PS calculating. In
the PS-matched patients, the rates of in-hospital NACE (3.6% vs. 5.5%, p¼0.114), in-
hospital MACE (2.0% vs. 2.1%, p¼0.833) and 1 year MACE (5.3% vs. 5.5%,
p¼0.895) were similar between TRA and TFA, but major bleeding (1.6% vs. 3.6%,
p¼0.036) and access site complications (2.0% vs. 7.5%, p< 0.001) were both lower in
the TRA group than in the TFA group.
Conclusions: TRA did not reduce the in-hospital and 1 year adverse clinical outcomes
compared with TFA in the PS-matched women patients, but TRA was associated with
fewer access site complications and major bleeding.
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